The Hong Kong Centre for Health Protection (CHP) of the Department of Health is following up 14 members of a tour group who developed symptoms of acute gastroenteritis after traveling to Egypt from February 16 to 25.
At this week’s major HIV/AIDS research meeting, Pfizer presented pivotal data of its experimental medicine, maraviroc, which tackles HIV in an entirely new way.
The United Nations Pan American Health Organization (PAHO), a regional arm of the UN World Health Organization (WHO), is assisting Paraguay in its efforts to control an outbreak of dengue fever that has affected thousands.
The results of what may be the most extensive comparison of two common disinfectants used by municipal water systems suggest that, from a security standpoint, traditional chlorination may be more effective than treatment with monochloramine.
In Iraq and other war-torn regions of the world, landmines cause widespread and devastating injury to combatants and civilians alike. The journal, Pain Medicine, has devoted a special issue to examining the social and physical impact of landmines and the treatment of pain caused by landmine injury.
A national series of interventions designed to improve the quality of care in health centers for three prevalent chronic conditions has improved processes of care for these conditions but did not improve intermediate clinical outcomes, according to results of a study collaboratively supported by the HHS Agency for Healthcare Research and Quality and Health Resources and Services Administration and complemented by a grant from the Commonwealth Fund.
Special courts that sentence people with mental illness who are convicted of misdemeanors and low-level felonies to treatment instead of jail have the potential to save taxpayers money, according to a RAND Corporation study conducted for the Council of State Governments Justice Center.
There is no clear benefit from a hormone commonly prescribed to enhance the effectiveness of infertility treatments, according to a new review of studies.
A study on patients with cirrhosis who had minimal hepatic encephalopathy (MHE), a condition in which behavioral, psychological and neurological changes are associated with advanced liver disease, found that cognitive function and health related quality-of-life improved when they took lactulose.
A review of the studies on the Model for End-Stage Liver Disease (MELD) found that it is an accurate predictor of survival of patients with a variety of liver diseases, is particularly useful in allocating organs for liver transplants, and can also be used to help determine the course of treatment in certain cases.